Biologics Market Outlook, Size, Share and Growth Forecast 2035
According to Payal Rabde, who specializes in biopharmaceuticals, biotechnology, and healthcare market research, with 4+ years of experience in market research and industry analysis, this research indicates that the biologics market is set to grow from USD 522.06 billion in 2026 to USD 1009.33 billion by 2035 at a 7.6% CAGR, driven by rising demand for targeted therapies and continuous biotechnology innovation. His analysis identifies oncology, microbial-derived biologics, in-house manufacturing, and monoclonal antibodies as the leading market segments, while highlighting North America's market leadership and Asia-Pacific's rapid expansion. The study also evaluates the competitive strategies of major companies, including Amgen, Merck & Co., F. Hoffmann-La Roche, Bristol-Myers Squibb, Sanofi, Bayer, AstraZeneca, Novartis, and Eli Lilly, shaping the global biologics landscape.
Last Updated : 10 August 2026Category: BiotechnologyInsight Code: 5108Format: PDF / PPT / Excel
Regulatory Framework for Leading Countries/Regions
Supply Demand Analysis
Production & Consumption Statistics
Export Import Statistics
Price Trend Analysis
Global Biologics Market Assessment
Overview
Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Vaccines
Others Types
Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
Oncology
Immunology
Infectiuos Disease
Other Indications
Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Diagnosis
Treatment
Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
Outsourced
In-house
Global Biologics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
North America Biologics Market Assessment
Overview
North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Vaccines
Others Types
North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
Oncology
Immunology
Infectiuos Disease
Other Indications
North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Diagnosis
Treatment
North America Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
Outsourced
In-house
Europe Biologics Market Assessment
Overview
Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Vaccines
Others Types
Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
Oncology
Immunology
Infectiuos Disease
Other Indications
Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Diagnosis
Treatment
Europe Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
Outsourced
In-house
Asia Pacific Biologics Market Assessment
Overview
Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Vaccines
Others Types
Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
Oncology
Immunology
Infectiuos Disease
Other Indications
Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Diagnosis
Treatment
Asia Pacific Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
Outsourced
In-house
Latin America Biologics Market Assessment
Overview
Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Vaccines
Others Types
Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
Oncology
Immunology
Infectiuos Disease
Other Indications
Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Diagnosis
Treatment
Latin America Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
Outsourced
In-house
Middle East and Africa Biologics Market Assessment
Overview
Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Vaccines
Others Types
Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
Oncology
Immunology
Infectiuos Disease
Other Indications
Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Diagnosis
Treatment
Middle East and Africa Biologics Market Size Value (US$) and Volume (Billion Tons), by Manufacturing Facility (2021 – 2033)
Outsourced
In-house
Company Profiles
Amgen
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Merck & Co.
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb
Sanofi
Bayer AG
AstraZeneca
GlaxoSmithKline Plc.
Novartis AG
Eli Lilly and Company
Conclusion & Recommendations
FAQ's
Answer : The biologics market is projected to grow from USD 522.06 billion in 2026 to USD 1009.33 billion by 2035, expanding at a CAGR of 7.6% due to rising chronic diseases and technological advancements.
Answer : Monoclonal antibodies dominated the market in 2024 due to their high specificity, longer half-life, fewer side effects, and increasing FDA approvals.
Answer : Food and Drug Administration, World Health Organization, American Cancer Society, ASCO.gov., National Institute of Biologics, CDSCO.
Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.
sales@towardshealthcare.com
+1 804-441-9344
Download Sample
USA : +1 8044 419344
sales@towardshealthcare.com